FDA Investigator Teresita C Mercado
Teresita C Mercado has conducted inspections on 7 sites in 4 countries as of 30 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
7
Last Inspection Date:
30 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
United Kingdom of Great Britain and Northern Ireland,
Switzerland,
Spain
FDA Investigators that have inspected at least one site in common with Teresita C Mercado:
Althea A Williams,
Ana S Cabrera,
Ann Marie Montemurro,
Ann Marie Schofield,
Annemarie Bodnar,
Burnell M Henry,
Byungja E Marciante,
Christian D Lynch (CDL),
Creighton T Tuzon,
Cynthia Jim, CSO,
Darcel T Bigelow,
Dawn L Wydner,
Eileen A Liu,
Elias N Paz Alonzo,
Eliezar Ramos,
Frank J Marciniak,
Gene D Arcy,
Hector A Carrero,
Helen B Ricalde,
J David Doleski,
Jacqueline Mdiaz Albertini,
Jean M Kelahan,
Jennifer Macmillan,
Joan A Loreng,
Joanne Pryzbylik,
Jonathan B Lewis,
Julie D Bringger,
Katherine E Jacobitz,
Kelly I Anderson,
Kimberly M Bigler,
LCDR Debra Emerson,
Margaret M Annes,
Marion Michaelis,
Mariza M Jafary,
Martha T Olone,
Mary T Carden,
Meihong Liu,
Michele L Forster, PhD,
Mihaly S Ligmond,
Omotunde O Osunsanmi,
Paula A Trost,
Prabhu P Raju,
Priscilla M Pastrana,
Qiao Y Bobo,
Ralph A Erickson,
Richard D Manney,
Richard T Riggie,
Rose Ashley,
Sarah Forney,
Sharmila Shrestha,
Sheryl A Kochman,
Simone E Pitts,
Stephen D Brown,
Steven E Kane,
Susan M Jackson,
Susan Yu,
Travis S Bradley,
Zhugong Liu
Teresita C Mercado's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2003 | FDA 483 Response | Ortho-Clinical Diagnostics, Inc. - Form 483R, 2003-10-28 |
April, 2018 | FDA 483 | Siwa Biotech Corp. - Form 483, 2018-04-27 |
August, 2003 | EIR | Ortho-Clinical Diagnostics, Inc. - EIR, 2003-08-14 |
May, 2009 | FDA 483 | Medion Grifols Diagnostics AG - Form 483, 2009-05-05 |
August, 2003 | FDA 483 | Ortho-Clinical Diagnostics, Inc. - Form 483, 2003-08-14 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more